세계의 카보프로스트 트로메타민 시장 : 제품 처방별, 용도별, 유통 경로별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

Carboprost Tromethamine Market, By Product Formulation, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

US $ 3,250 ￦ 4,535,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650 ￦ 6,488,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650 ￦ 7,884,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

보고서 하이라이트

카보프로스트 트로메타민 시장 규모는 2022년 15억 960만 달러였으며, 2023년부터 2030년까지 CAGR 4.3%로 추이하며 성장할 것으로 예상됩니다.

카보프로스트 트로메타민 시장 - 시장 역학 :

• 산후 출혈의 유병률 증가, 정부의 대처, 헬스케어 정책이 시장 성장을 견인 할 것으로 예상됩니다.
• 산후 출혈은 출산 후의 과도한 출혈로, 세계적으로 임산부의 이환율과 사망률의 주요 원인이 되고 있습니다. 산후 출혈(PPH)의 유병률이 증가함에 따라 카보프로스트 트로메타민과 같은 산후 출혈을 조절하고 관리하는 데 도움이되는 약물에 대한 수요가 증가하고 있습니다. 또한 출생률이 높기 때문에 산후 출혈의 증례도 증가하고 있습니다. 따라서 PPH의 유병률 상승은 세계의 카보프로스트 트로메타민 시장 성장을 뒷받침할 것으로 보입니다. 그러나 고도로 숙련된 건강 관리 전문가의 부족이 시장 수요를 방해하는 요인이 되고 있습니다. 또한, 의료 및 정부 기관은 임산부 건강을 개선하고 임산부 사망률을 최소화하기 위한 여러 이니셔티브를 가능하게 합니다. 이에 따라 산후 출혈을 효과적으로 관리하는 데 중점을 둔 프로그램이 실시되고 있습니다. 그 결과 이러한 노력은 카보프로스트 트로메타민 등 의약품 수요를 증가시켜 카보프로스트 트로메타민 시장 성장을 가속하게 됩니다.

카보프로스트 트로메타민 시장-세분화 분석 :

• 카보프로스트 트로메타민 시장은 제품 처방, 용도, 유통 채널, 지역에 따라 세분화됩니다.
• 제품은 임신 낙태와 분만 후 출혈 치료제로 분류됩니다. 분만 후 출혈 치료 부문은 우위를 유지하는 것으로 보입니다. 이 부문의 성장은 산후 출혈(PPH)의 유병률 증가로 인한 것입니다. 출산 건수 증가로 산후 출혈의 발생률도 상승하고 있습니다.
• 시장은 용도에 따라 재구성용 분말 제형과 주사용 제형의 두 가지로 분류됩니다. 주사용 제형 분야는 시장의 급속한 성장이 예상됩니다. 주사제는 투여량의 제어와 작용 발현의 속도 등 이유로 임상 현장에서 일반적으로 사용되고 있습니다. 또한, 주사제는 종종 효과적이고 신속한 치료가 필수적인 분만 후 출혈과 같은 응급 상황에서 채택됩니다.
• 시장은 유통 채널에 따라 온라인 약국, 병원 약국, 소매 약국의 세 가지로 분류됩니다. 예측 기간 동안 가장 큰 수익 점유율을 차지하는 것은 병원 약국입니다. 병원 약국은 카보프로스트 트로메타민과 같은 의약품에 필수적인 유통 채널입니다. 또한, 병원 약국은 특히 산후 출혈이나 이 약의 사용을 필요로 하는 다양한 의료 문제의 경우 필요에 따라 제제하고 재고할 가능성이 높습니다.

카보프로스트 트로메타민 시장-지리적 통찰

지리적으로, 이 시장은 북미, 남미, 유럽, 아시아 태평양, 중동 및 아프리카 등 각 지역으로 퍼져 있습니다. 이 지역은 비즈니스를 제공하는 국가에 따라 더욱 세분화 됩니다.

카보프로스트 트로메타민 시장-경쟁 구도 :

분만 후 출혈을 관리하기위한 의료 기술 및 기술 기술의 발전은 카보프로스트 트로메타민과 같은 의약품 시장에 영향을 줄 것으로 예상됩니다. 또한 시장 성장은 유사한 적응증에 대한 다른 치료법과 약물의 영향을 받을 수 있습니다. 또한 주요 기업은 제휴, R&D 활동, M&A, 파트너십 등 전략을 채택하고 있습니다. 예를 들어, 2022년 2월, Amneal은 4개의 제네릭 주사제가 승인되었습니다고 발표했습니다. 또한, 아자시티딘 100mg, 아트로핀 황산염 주사액 USP 0.5mg/5mL, 카보프로스트트로메타민 주사액 USP 250mcg/mL, 덱사메타손 인산나트륨 주사액 USP 10mg/mL은 미국 식품의약국(FDA)으로부터 ANDA을 취득했습니다.

목차

제1장 카보프로스트 트로메타민 시장 개요

• 조사 범위
• 시장 추정 연도

제2장 주요 요약

• 시장 분석
• 경쟁 인사이트

제3장 카보프로스트 트로메타민-주요 시장 동향

• 시장 성장 촉진 요인
• 시장 성장 억제 요인
• 시장 기회
• 향후 시장 동향

제4장 카보프로스트 트로메타민 산업 조사

• PEST 분석
• Porter's Five Forces 분석
• 성장 전망 맵핑
• 규제 프레임워크 분석

제5장 카보프로스트 트로메타민 시장 : COVID-19 영향 분석

• COVID-19 이전 영향 분석
• COVID-19 이후 영향 분석

제6장 카보프로스트 트로메타민 시장 상황

• 카보프로스트 트로메타민 시장 점유율 분석(2022년)
• 주요 제조사별 분석 데이터
  • 기존 기업 분석
  • 신흥 기업 분석

제7장 카보프로스트 트로메타민 시장-제품 처방별

• 개요
  • 제품 배합별 부문 점유율 분석
  • 낙태
  • 산후 출혈의 치료

제8장 카보프로스트 트로메타민 시장-용도별

• 개요
  • 용도별 부문 점유율 분석
  • 반환용 분말
  • 주사용 제제

제9장 카보프로스트 트로메타민 시장-유통 채널별

• 개요
  • 판매 채널별 부문 점유율 분석
  • 온라인 약국
  • 병원 약국
  • 소매 약국

제10장 카보프로스트 트로메타민 시장-지역별

• 소개
• 북미
  • 개요
  • 북미의 주요 제조사
  • 미국
  • 캐나다
• 유럽
  • 개요
  • 유럽의 주요 제조사
  • 독일
  • 이탈리아
  • 영국
  • 프랑스
  • 러시아
  • 네덜란드
  • 스웨덴
  • 폴란드
  • 기타
• 아시아 태평양(APAC)
  • 개요
  • 아시아 태평양의 주요 제조사
  • 인도
  • 중국
  • 일본
  • 한국
  • 호주
  • 태국
  • 인도네시아
  • 필리핀
  • 기타
• 남미
  • 개요
  • 남미의 주요 제조사
  • 브라질
  • 멕시코
  • 아르헨티나
  • 콜롬비아
  • 기타
• 중동 및 아프리카
  • 개요
  • 중동 및 아프리카의 주요 제조사
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 이스라엘
  • 터키
  • 알제리
  • 이집트
  • 기타

제11장 주요 벤더 분석-카보프로스트 트로메타민 산업

• 경쟁 대시보드
• 기업 개요
  • Taj Pharmaceuticals Limited
  • Pfizer Inc.
  • Apionex Pharma Pvt Ltd.
  • MANUS AKTTEVA BIOPHARMA LLP
  • Biosynth
  • Monvi labs
  • Amneal Pharmaceuticals LLC
  • ChemScene
  • Bio-Techne
  • ANGUS Chemical Company
  • WATSON INTERNATIONAL LIMITED
  • SimSon Pharma Limited
  • Ryvis Pharma
  • Universal Biologicals
  • Woodward Pharma
  • Merck KGaA
  • Dr. Reddy's Laboratories Ltd.
  • BioSpectra Inc.

제12장 애널리스트의 전방위 전망

LYJ

영문 목차

영문목차

REPORT HIGHLIGHT

Carboprost tromethamine market size was valued at USD 1,509.6 Million in 2022, expanding at a CAGR of 4.3% from 2023 to 2030.

Carboprost tromethamine also referred to as hemabate, is a prostaglandin used to treat postpartum hemorrhage and severe bleeding post-child delivery in females. Additionally, it is utilized as a contraceptive pill to induce abortion by gradual expulsion of the placenta and causing uterine contractions. The drug is provided anytime between the third and fifth month of the pregnancy. Increased contractions are the result of it working on the F receptor or the E2 receptor sites present in the uterine muscles.

Carboprost Tromethamine Market - Market Dynamics:

• The increasing prevalence of postpartum hemorrhage, government initiatives, and healthcare policies drives the market growth

• Postpartum hemorrhage is excessive bleeding after childbirth is a major cause of maternal morbidity and mortality worldwide. The growing use of prevalence of postpartum hemorrhage (PPH) is increasing the demand for drugs such as carboprost tromethamine that help to control and manage postpartum bleeding. Additionally, due to the high birthrate, postpartum hemorrhage cases also rise. Thus the rising prevalence of PPH will boost the global carboprost tromethamine market growth. However, the lack of highly skilled healthcare professionals is a reason to hamper the market demand. Moreover, healthcare and government organizations are enabling several initiatives to improve maternal healthcare and minimize maternal mortality. In line with this, it involves programs that focus on managing postpartum hemorrhage effectively. As a result, the initiatives increase the demand for drugs such as carboprost tromethamine, which will drive carboprost tromethamine market growth.

Carboprost Tromethamine Market - Key Insights:

• As per the analysis shared by our research analyst, the global carboprost tromethamine market is estimated to grow annually at a CAGR of around 4.3% over the forecast period (2023-2030)

• The carboprost tromethamine industry is projected to grow at a significant rate due to the rise of high birthrate, postpartum hemorrhage cases

• Based on product formulation segmentation, postpartum hemorrhage treatment was predicted to show maximum market share in the year 2022

• On the basis of region, North America was the leading revenue generator in 2022

Carboprost Tromethamine Market- Segmentation Analysis:

• The global carboprost tromethamine market is segmented on the basis of product formulation, application, distribution channel, and region.

• The market is divided into two categories based on product formulation: pregnancy abortion and postpartum hemorrhage treatment. The postpartum hemorrhage treatment segment is likely to maintain its dominance. The growth of the segment is attributed to the increasing prevalence of postpartum hemorrhage (PPH). Due to the increasing number of birth cases, there is also a rising incidence of postpartum hemorrhage.

• The market is divided into two categories based on application: powder for reconstitution and injectable formulation. The injectable formulation segment is accounted to witness speedy growth in the market. The injectable formulations are commonly used in clinical settings for controlled dosage administration and their quick onset of action. Additionally, the injectable form is often employed in emergencies, like postpartum hemorrhage, where effective and rapid treatment is essential.

• The market is divided into three categories based on distribution channels: online pharmacies, hospital pharmacies, and retail pharmacies. The hospital pharmacies segment is likely to possess the largest revenue share over the forecast period. Hospital pharmacies are an essential distribution channel for drugs like carboprost tromethamine. In addition, hospital pharmacies are likely to dispense and stock them as required, particularly in cases of postpartum hemorrhage or different medical issues requiring the use of this medication.

Carboprost Tromethamine Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Carboprost Tromethamine Market- Competitive Landscape:

Advances in the medical techniques and technology techniques for managing postpartum hemorrhage are expected to affect the market for medications like Carboprost Tromethamine. The market growth may also be influenced by other treatments or medications for similar indications. Moreover, major players are also adopting types of strategies such as collaboration, R&D activities, mergers & acquisitions, and partnerships. For instance, in February 2022, Amneal introduced that four generic injectables products are now approved. Moreover, azacitidine 100 mg, atropine sulfate injection, USP 0.5 mg/5 mL, carboprost tromethamine injection, USP 250 mcg/mL, and dexamethasone sodium phosphate injection, USP 10 mg/mL have received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA).

Recent Developments:

For instance, in March 2021, Sunny Pharmtech Inc. released a statement announcing that the US FDA approved its ANDA ("Abbreviated New Drug Application") of Carboprost Tromethamine Injection. Additionally, carboprost tromethamine Injection is indicated for aborting pregnancy.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CARBOPROST TROMETHAMINE MARKET KEY PLAYERS

• Taj Pharmaceuticals Limited
• Pfizer Inc.
• Apionex Pharma Pvt Ltd.
• MANUS AKTTEVA BIOPHARMA LLP
• Biosynth
• Monvi labs
• Amneal Pharmaceuticals LLC
• ChemScene
• Bio-Techne
• ANGUS Chemical Company
• WATSON INTERNATIONAL LIMITED
• SimSon Pharma Limited
• Ryvis Pharma
• Universal Biologicals
• Woodward Pharma
• Merck KGaA
• Dr. Reddy's Laboratories Ltd.
• BioSpectra Inc.

GLOBALCARBOPROST TROMETHAMINE MARKET, BY PRODUCT FORMULATION

• Pregnancy Abortion
• Postpartum Hemorrhage Treatment

GLOBAL CARBOPROST TROMETHAMINE MARKET, BY APPLICATION

• Powder for Reconstitution
• Injectable Formulation

GLOBAL CARBOPROST TROMETHAMINE MARKET, BY DISTRIBUTION CHANNEL

• Online Pharmacies
• Hospital Pharmacies
• Retail Pharmacies

GLOBAL CARBOPROST TROMETHAMINE MARKET, BY REGION

• North America
• The U.S.
• Canada

• Europe
• Germany
• France
• Italy
• Spain

• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe

• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC

• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM

• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Carboprost Tromethamine Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Carboprost Tromethamine Market Snippet by Product Formulation
  • 2.1.2. Carboprost Tromethamine Market Snippet by Application
  • 2.1.3. Carboprost Tromethamine Market Snippet by Distribution Channel
  • 2.1.4. Carboprost Tromethamine Market Snippet by Country
  • 2.1.5. Carboprost Tromethamine Market Snippet by Region
• 2.2. Competitive Insights

3. Carboprost Tromethamine Key Market Trends

• 3.1. Carboprost Tromethamine Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Carboprost Tromethamine Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Carboprost Tromethamine Market Opportunities
• 3.4. Carboprost Tromethamine Market Future Trends

4. Carboprost Tromethamine Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Carboprost Tromethamine Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Carboprost Tromethamine Market Landscape

• 6.1. Carboprost Tromethamine Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Carboprost Tromethamine Market - By Product Formulation

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product Formulation, 2022&2030 (%)
  • 7.1.2. Pregnancy Abortion
  • 7.1.3. Postpartum Hemorrhage Treatment

8. Carboprost Tromethamine Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
  • 8.1.2. Powder for Reconstitution
  • 8.1.3. Injectable Formulation

9. Carboprost Tromethamine Market - By Distribution Channel

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022&2030 (%)
  • 9.1.2. Online Pharmacies
  • 9.1.3. Hospital Pharmacies
  • 9.1.4. Retail Pharmacies

10. Carboprost Tromethamine Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Carboprost Tromethamine Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Carboprost Tromethamine Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Carboprost Tromethamine Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Carboprost Tromethamine Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Carboprost Tromethamine Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Carboprost Tromethamine Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. Taj Pharmaceuticals Limited
  • 11.2.2. Pfizer Inc.
  • 11.2.3. Apionex Pharma Pvt Ltd.
  • 11.2.4. MANUS AKTTEVA BIOPHARMA LLP
  • 11.2.5. Biosynth
  • 11.2.6. Monvi labs
  • 11.2.7. Amneal Pharmaceuticals LLC
  • 11.2.8. ChemScene
  • 11.2.9. Bio-Techne
  • 11.2.10. ANGUS Chemical Company
  • 11.2.11. WATSON INTERNATIONAL LIMITED
  • 11.2.12. SimSon Pharma Limited
  • 11.2.13. Ryvis Pharma
  • 11.2.14. Universal Biologicals
  • 11.2.15. Woodward Pharma
  • 11.2.16. Merck KGaA
  • 11.2.17. Dr. Reddy's Laboratories Ltd.
  • 11.2.18. BioSpectra Inc.

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us

관련자료